Solid growth in listed companies is predicted for the forthcoming NZX reporting season, which is expected to be dominated by the six property companies.
Starting with Z Energy and Xero on May 12, a total 21 companies are scheduled to deliver quarterly reports, running through to May 27 and Fisher & Paykel Healthcare's report.
Forsyth Barr broker Suzanne Kinnaird said the brokerage's analysts were forecasting total revenue growth of more than 17.4%, at a median level, with operating profit - earnings before interest and tax - forecast at more than 9.3%.
"Given the small sample size, with large cap companies skewing the aggregated growth figures, we choose to focus on the median growth figures for this reporting season,'' Mrs Kinnaird said.
She expected steady results from listed property sector during the reporting season, with earnings per share up more than 3% for most of the six listed property vehicles.
"We are expecting strong pre-tax earnings growth driven by acquisitions, developments and lower interest costs. However, this will be partially offset by increased tax and equity issuance, resulting in steady earnings per share gains of between 2% to more than 5%,'' she said.
She said Argos Property was expected to confirm solid revaluation gains, after a more than 2% gain in the first half.
There was expected to be steady earnings per share growth of more than 3.4%, with a flat dividend given the impact of higher tax for Argosy.
A feature of the Goodman Property Trust for full-year 2016 has been strong development activity funded by asset recycling, noting strong revaluation gains for Goodman have already been confirmed, Mrs Kinnaird said.
Ryman Healthcare was expected to show strong growth in all areas, but gains in new sales could yet be affected by the late arrival of new stock in New Zealand.
"An update on progress in Melbourne will be of interest,'' Mrs Kinnaird said.
Dunedin-based cancer diagnostic company Pacific Edge is to report, with Mrs Kinnaird more focused on its outlook commentary than results, given it is still in the early commercialisation stages; largely in the US.
"We're looking for commentary on progress in the key US market, an update on its plans in Southeast Asia, further growth in revenue and an update on growth in lab throughput,'' she said.
Given last week's confirmation of Z Energy being given approval of its takeover plans for the New Zealand assets of Caltex, Mrs Kinnaird expects its focus will be explaining synergies and its plans for merging.
"The financial result itself will be very strong and a new record,'' she said.
On Xero, Mrs Kinnaird said expectations of revenue of $214million from Australian and UK subscriptions was "key'' for full-year 2016.
"The US market remains important but subscription growth in absolute terms will be small,'' she said.
